Related references
Note: Only part of the references are listed.STING regulates BCR signaling in normal and malignant B cells
Chih-Hang Anthony Tang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma
Ioanna Xagoraris et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma
Rana Falahat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer
John Kwon et al.
CANCER DISCOVERY (2020)
cGAS-STING pathway in cancer biotherapy
Yang Wang et al.
MOLECULAR CANCER (2020)
Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production
Hiroyasu Konno et al.
ONCOGENE (2018)
B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses
Melissa M. Walker et al.
JOURNAL OF IMMUNOLOGY (2018)
Enhancing immunotherapy of STING agonist for lymphoma in preclinical models
Adrienne Sallets et al.
BLOOD ADVANCES (2018)
Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure
Anna M. Gram et al.
MOLECULAR IMMUNOLOGY (2017)
STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy
Lekh N. Dahal et al.
CANCER RESEARCH (2017)
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site
Takayuki Ohkuri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Mechanisms of transcriptional activation of the stimulator of interferon genes by transcription factors CREB and c-Myc
Yan-Yan Wang et al.
ONCOTARGET (2016)
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Ramona Crescenzo et al.
CANCER CELL (2015)
Positive feedback regulation of type I interferon by the interferon-stimulated gene STING
Feng Ma et al.
EMBO REPORTS (2015)
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Olivier Demaria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Juan Fu et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2014)
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry
Fredrik Ellin et al.
BLOOD (2014)
The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK plus anaplastic large cell lymphoma
Vassilis Atsaves et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
Mamiko Sakata-Yanagimoto et al.
NATURE GENETICS (2014)
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
Teresa Palomero et al.
NATURE GENETICS (2014)
Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors
Vivien Mak et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
M. Nickelsen et al.
ANNALS OF ONCOLOGY (2009)
Share Paper
